Multi-modality approach to identify Nav1.7 inhibitors for pain - Sophion

Multi-modality approach to identify Nav1.7 inhibitors for pain


Author(s): Bryan Moyer


Dr. Bryan Moyer, Amgen – talk from ICMS 2019, the United States

Title: Multi-modality approach to identify NaV1.7 inhibitors for pain

Contact

Contact Sophion

Sophion Bioscience A/S
Baltorpvej 154, 2750 Ballerup, Denmark
Telephone: +45 44 60 88 00

You need to fill in all required fields.

When opting-in for our newsletter you will receive 4-6 newsletters per year. You can always opt-out directly from the newsletters. For more information see our privacy policy